Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Farmakoterapija fibrilacije atrija

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • المؤلفون: Robert Bernat
  • المصدر:
    Medicus; ISSN 1330-013X (Print); ISSN 1848-8315 (Online); Volume 19; Issue 2_Kardiologija
  • نوع التسجيلة:
    Electronic Resource
  • الدخول الالكتروني :
    https://hrcak.srce.hr/65108
    https://hrcak.srce.hr/file/97502
  • معلومة اضافية
    • Additional Titles:
      Pharmacological Therapy of Atrial Fibrillation
    • Publisher Information:
      PLIVA CROATIA d.o.o. 2010
    • نبذة مختصرة :
      Fibrilacija atrija (FA) najčešća je aritmija u kliničkoj praksi. Prevalencija i incidencija značajno se povećavaju s dobi. Strategija liječenja ovisi o brojnim kliničkim parametrima koji određuju vrstu FA (paroksizmalna, perzistentna, permanentna). Ključna odluka odnosi se na kontrolu ritma ili frekvencije, što definira terapijsku strategiju. Bez obzira na odabrani pristup, nužno je odabrati optimalan način prevencije tromboembolijskih komplikacija, tj. antitrombotsku terapiju. Iako postoje brojne i dijelom vrlo učinkovite nefarmakološke metode za odabrane bolesnike s FA, lijekovi su još uvijek dominantan način liječenja i glavna su tema ovog pregleda s najnovijim podacima i terapijskim preporukama.
      Atrial fibrillation (AF) is the most common arrhythmia in clinical practice. Prevalence and incidence increase significantly with age. Treatment strategy depends on numerous clinical parameters which also determine the type of AF (paroxysmal, persistent, permanent). The most important decision involves rhythm or rate control and defines the therapeutic strategy. Regardless of the preferred approach, it is necessary to select the appropriate means for the prevention of thromboembolic complications, i.e. antithrombotic therapy. Although there are several and largely very efficient nonpharmacological interventions for selected patients with AF, drug therapy is still the mainstay of treatment and the main topic of this review, including most recent data and therapeutic recommendations.
    • الموضوع:
      fibrilacija atrija; epidemiologija; farmakoterapija; atrial fibrillation; epidemiology; pharmacotherapy; text; info:eu-repo/semantics/article; info:eu-repo/semantics/publishedVersion
    • Availability:
      Open access content. Open access content
      info:eu-repo/semantics/openAccess
    • Note:
      application/pdf
      Croatian
    • Other Numbers:
      HRCAK oai:hrcak.srce.hr:65108
      1363147324
    • Contributing Source:
      HRCAK PORTAL ZNANSTVENIH CASOPISA REPUB
      From OAIster®, provided by the OCLC Cooperative.
    • الرقم المعرف:
      edsoai.on1363147324
HoldingsOnline